Drugs / MUCOPOLYSACCHARIDE POLYSULFATE
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT01943006 | May 2015 → Feb 2017 | thrombophlebitis | Medinova AG | Completed | No outcome recorded |
| Phase 3 | NCT01203397 | Sep → Dec 2014 | varicose disease | EMS | Withdrawn | No outcome recorded Stop: Business |
| Phase 3 | NCT01426035 | Sep → Dec 2014 | varicose disease | EMS | Withdrawn | No outcome recorded Stop: Business |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04534426 Comparator | Dec 2018 → Dec 2019 | impacted teeth, multiple | Abant Izzet Baysal University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MUCOPOLYSACCHARIDE POLYSULFATE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01203397 ↗ |
| Known as | MPSP | “The aim of the present study was to determine if topical application of arnica or mucopolysaccharide polysulfate (MPSP) reduces pain, trismus, and edema following the removal...” PMID 37913818 ↗ Oct 2023 |
| Modality | Small molecule | — CHEMBL2109199 ↗ |
| Route | Topical | “APLIED 4 TIMES/DAY AT LESION” NCT01203397 ↗ |